CAPITAL POSITION CONTINUES TO STRENGTHEN AS CET1 RATIO INCREASES TO 11.9%, TOP QUARTILE OF PEER GROUP ONGOING IMPROVEMENT IN FUNDING...
Fourth
Underlying Net Income of $412 million and EPS of $0.85 CET1 ratio of 10.8%; LDR 79.6% 2024 Net Income of...
Unity Biotechnology, Inc.SOUTH SAN FRANCISCO, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) , a biotechnology company...